Literature DB >> 16878563

Impact of interseed attenuation and tissue composition for permanent prostate implants.

Jean-François Carrier1, Luc Beaulieu, François Therriault-Proulx, René Roy.   

Abstract

The purpose is to evaluate the impact of interseed attenuation and prostate composition for prostate treatment plans with 125I permanent seed implants using the Monte Carlo (MC) method. The effect of seed density (number of seeds per prostate unit volume) is specifically investigated. The study focuses on treatment plans that were generated for clinical cases. For each plan, four different dose calculation techniques are compared: TG-43 based calculation, superposition MC, full MC with water prostate, and full MC with realistic prostate tissue. The prostate tissue description is from the ICRP report 23 (W. S. Snyer, M. J. Cook, E. S. Nasset, L. R. Karkhausen, G. P. Howells, and I. H. Tipton, "Report of the task group on reference man," Technical Report 23, International Commission on Radiological Protection, 1974). According to the comparisons, the seed density has an influence on interseed attenuation. A plan with a typical low seed density (42 0.6 mCi seeds in a 26 cm3 prostate) suffers a 1.2% drop in the CTV D90 value due to interseed attenuation. A drop of 3.0% is calculated for a higher seed density (75 0.3 mCi seeds, same prostate). The influence of the prostate composition is similar for all seed densities and prostate sizes. The difference between MC simulations in water and MC simulations in prostate tissue is between 4.4% and 4.8% for the D90 parameter. Overall, the effect on D90 is ranging from 5.8% to 12.8% when comparing clinically approved TG-43 and MC simulations in prostate tissue. The impact varies from one patient to the other and depends on the prostate size and the number of seeds. This effect can reach a significant level when reporting correlations between clinical effect and deposited dose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878563     DOI: 10.1118/1.2168295

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

1.  Reconstruction of brachytherapy seed positions and orientations from cone-beam CT x-ray projections via a novel iterative forward projection matching method.

Authors:  Damodar Pokhrel; Martin J Murphy; Dorin A Todor; Elisabeth Weiss; Jeffrey F Williamson
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

2.  A dosimetry method for low dose rate brachytherapy by EGS5 combined with regression to reflect source strength shortage.

Authors:  Kenichi Tanaka; Kunihiko Tateoka; Osamu Asanuma; Ken-Ichi Kamo; Kaori Sato; Hiromitsu Takeda; Masaru Takagi; Masato Hareyama; Jun Takada
Journal:  J Radiat Res       Date:  2014-01-20       Impact factor: 2.724

3.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

4.  Fast patient-specific Monte Carlo brachytherapy dose calculations via the correlated sampling variance reduction technique.

Authors:  Andrew Sampson; Yi Le; Jeffrey F Williamson
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

5.  A comparison of the dose distributions between the brachytherapy 125I source models, STM1251 and Oncoseed 6711, in a geometry lacking radiation equilibrium scatter conditions.

Authors:  Kenichi Tanaka; Ken-ichi Kamo; Kunihiko Tateoka; Osamu Asanuma; Kaori Sato; Hiromitsu Takeda; Koh-ichi Sakata; Jun Takada
Journal:  J Radiat Res       Date:  2015-01-24       Impact factor: 2.724

6.  An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy.

Authors:  Habib Safigholi; Dariush Sardari; Somaye Karimi Jashni; Seied Rabi Mahdavi; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

Review 7.  Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.

Authors:  Christian Kirisits; Mark J Rivard; Dimos Baltas; Facundo Ballester; Marisol De Brabandere; Rob van der Laarse; Yury Niatsetski; Panagiotis Papagiannis; Taran Paulsen Hellebust; Jose Perez-Calatayud; Kari Tanderup; Jack L M Venselaar; Frank-André Siebert
Journal:  Radiother Oncol       Date:  2013-11-30       Impact factor: 6.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.